CONTROL SET, BLOOD C

The contract pertains to the procurement of a stabilized whole blood matrix control system designated as CONTROL SET, BLOOD CHEMISTRY, identified by NSN 6550-01-670-0237, intended for statistical process control on Sysmex hematology analyzers. Each unit of issue consists of a tri-pack containing four vials at each of three concentrations—low, normal, and high—for a total of twelve vials, each containing 2.0 ml of product. The control includes stabilized human erythrocytes, mammalian and simulated leukocytes, and a platelet component suspended in a plasma-like medium, enabling monitoring of up to twenty-two parameters. Storage is strictly regulated to refrigeration between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit), with freezing prohibited. The item is classified as a Type I (Code C) medical product with a non-extendable shelf life of three months, and no more than thirteen days may have elapsed between the date of manufacture and delivery to the government. All packaging and labeling must comply with Medical Marking Standard No. 1 (MMS No. 1), superseding MIL-STD-129, and must clearly display the date of manufacture, expiration date, contract number, and lot number in accordance with MMS1C. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transit at minimum carrier rates to the designated delivery point in Philadelphia, Pennsylvania. The solicitation, issued under SPE2DS-26-T-033K, requires delivery within twenty days after award, with FOB destination terms applying. The item is subject to DLA packaging requirements (RP001), hazardous material handling standards including Fed-Std-313 and TQ IP025, and compliance with the Hazard Communication Standard. All contractors must adhere to DFARS clauses including safeguarding covered defense information, cyber incident reporting, and limitations on the use of prohibited telecommunications equipment. Invoicing must be submitted exclusively via the Wide Area WorkFlow (WAWF) system, and the contractor must provide a validated Unique Entity Identifier (UEI) and CAGE code. The product is subject to technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, and the contractor must ensure full compliance with medical marking, shelf-life, and packaging standards throughout the supply chain. The acquisition is unrestricted and does not specify a set-aside,